Jason Hoitt

Insider Reports History

Location
Bedford, MA
Signature
/s/ Jonathan Allan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Hoitt:

Company Role Class Num Shares Value Price $ Report Date Ownership
Stoke Therapeutics, Inc. Chief Patient Officer Common Stock 1,802 $17,533 $9.73 18 Jun 2025 Direct
Stoke Therapeutics, Inc. Chief Patient Officer Employee Stock Option (Right to Buy) 72,000 17 Feb 2026 Direct
Stoke Therapeutics, Inc. Chief Patient Officer Restricted Stock Units 48,000 17 Feb 2026 Direct
Provention Bio, Inc. Chief Commercial Officer Option to Purchase Common Stock 0 27 Apr 2023 Direct

Insider Reports Filed by Jason Hoitt

Symbol Company Period Transactions Value $ Form Type Role Filing Time
STOK Stoke Therapeutics, Inc. 17 Feb 2026 2 $0 4 Chief Patient Officer 19 Feb 2026, 16:21
STOK Stoke Therapeutics, Inc. 18 Jun 2025 0 $0 3 Chief Patient Officer 23 Jun 2025, 16:16
/report/000149315223013904-hoitt-jason-2023-04-27 Provention Bio, Inc. 27 Apr 2023 5 $0 4 Chief Commercial Officer 27 Apr 2023, 18:00
/report/000149315223005078-hoitt-jason-2023-02-10 Provention Bio, Inc. 10 Feb 2023 1 -$45,005 4 Chief Commercial Officer 14 Feb 2023, 18:16
/report/000149315223001208-hoitt-jason-2023-01-10 Provention Bio, Inc. 10 Jan 2023 1 $0 4 Chief Commercial Officer 11 Jan 2023, 20:10
/report/000149315222035096-hoitt-jason-2022-12-08 Provention Bio, Inc. 08 Dec 2022 2 $0 4 Chief Commercial Officer 09 Dec 2022, 19:31
/report/000149315222001752-hoitt-jason-2022-01-18 Provention Bio, Inc. 18 Jan 2022 1 $0 4 Chief Commercial Officer 20 Jan 2022, 16:20
/report/000149315221011579-hoitt-jason-2021-05-12 Provention Bio, Inc. 12 May 2021 1 $0 4 Chief Commercial Officer 14 May 2021, 19:39